Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Harold Engstrom who wrote (3170)	6/2/1999 9:17:00 PM
From: quidditch	Read Replies (1) \| Respond to of 10280

Thread: What do all of you make of Round II of the FDA warning letter? This seems to be, in large part, a rehash of the March 27 letter released in April, addressing the same substantive points. Could SEPR really have blown off the thrust of the FDA comments. Does this sound like TB's style? Or is SEPR so stretched from a management perspective that it is unable to bring to bear appropriate resources to address this. When you are dealing with your principal Federal regulator, you do not blithely ignore their public remonstrations. Not a good long term strategy. Perplexed. Steven